CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Polycystic ovary syndrome - Management
Basis for recommendation
Use of a hormonal contraceptive
- A Cochrane systematic review provides evidence that combined oral contraceptives (COCs) are effective in the treatment of acne vulgaris. In general, the efficacy of COCs in treating acne vulgaris is independent of the particular oestrogen or progestogen component used; however, evidence suggests that the addition of cyproterone acetate as the progestogen component may further increase effectiveness.
- In most women, the safety profile of COCs is good, and they have additional benefits for women who require contraception.
© NHS Institute for Innovation and Improvement